HCM - HUTCHMED (China) Limited - ADR
IEX Last Trade
17.45
-0.310 -1.777%
Share volume: 81,117
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$17.76
-0.31
-1.75%
Fundamental analysis
14%
Profitability
0%
Dept financing
9%
Liquidity
75%
Performance
13%
Performance
5 Days
1.10%
1 Month
-3.06%
3 Months
-7.43%
6 Months
14.73%
1 Year
10.03%
2 Year
40.95%
Key data
Stock price
$17.45
DAY RANGE
N/A - N/A
52 WEEK RANGE
$11.93 - $21.92
52 WEEK CHANGE
$0.13
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Christian Hogg
Region: US
Website: https://www.hutch-med.com/
Employees: 5,878
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: https://www.hutch-med.com/
Employees: 5,878
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
HUTCHMED China Ltd, formerly Hutchison China Meditech Ltd, is an investment holding company principally engaged in the manufacturing and sale of drugs.
Recent news